CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Option exercise | +31,000 | $3.80 | $118K | 120,551 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Sale | −7,124 | $20.89 | $149K | 113,427 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Sale | −70,801 | $22.06 | $1.6M | 42,626 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Sale | −22,075 | $22.59 | $499K | 20,551 |
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | −50,000 | 225,000 | ||
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | −19,000 | 64,000 | ||
| 2019-03-01 | Kalb Michael Wayne SVP and CFO | Option exercise · Stock Option (Right to Buy) | −31,000 | 86,000 | ||
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,605 | $1.40 | $4K | 357,097 |
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,167 | $2.50 | $10K | 361,264 |
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,771 | $2.95 | $8K | 364,035 |
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Sale | −9,543 | $20.67 | $197K | 354,492 |
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,605 | 28,645 | ||
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −4,167 | 16,664 | ||
| 2019-02-28 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,771 | 64,229 | ||
| 2019-02-28 | Kennedy Joseph T General Counsel | Option exercise | +2,605 | $1.40 | $4K | 33,865 |
| 2019-02-28 | Kennedy Joseph T General Counsel | Option exercise | +18,750 | $2.50 | $47K | 52,615 |
| 2019-02-28 | Kennedy Joseph T General Counsel | Option exercise | +3,438 | $2.95 | $10K | 56,053 |
| 2019-02-28 | Kennedy Joseph T General Counsel | Option exercise | +2,438 | $3.80 | $9K | 58,491 |
| 2019-02-28 | Kennedy Joseph T General Counsel | Sale | −27,231 | $20.72 | $564K | 31,260 |
| 2019-02-28 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −2,605 | 28,645 |
Page 69 of 95 · 1,885 trades